ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 139 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 3.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $181,000 | -23.9% | 21,670 | -18.7% | 0.01% | -28.6% |
| Q1 2017 | $238,000 | +17.2% | 26,638 | +15.5% | 0.01% | +40.0% |
| Q4 2016 | $203,000 | +141.7% | 23,061 | -2.5% | 0.01% | +150.0% |
| Q2 2016 | $84,000 | -47.5% | 23,641 | -56.4% | 0.00% | -60.0% |
| Q1 2016 | $160,000 | -65.6% | 54,268 | -50.8% | 0.01% | -37.5% |
| Q4 2015 | $465,000 | +440.7% | 110,271 | +487.3% | 0.01% | +700.0% |
| Q3 2015 | $86,000 | -33.8% | 18,777 | +4.1% | 0.00% | -50.0% |
| Q2 2015 | $130,000 | -65.3% | 18,043 | -64.5% | 0.00% | -75.0% |
| Q1 2015 | $375,000 | +77.7% | 50,826 | +14.1% | 0.01% | +166.7% |
| Q4 2014 | $211,000 | +95.4% | 44,562 | +46.8% | 0.00% | +50.0% |
| Q3 2014 | $108,000 | -61.6% | 30,356 | -50.9% | 0.00% | -50.0% |
| Q2 2014 | $281,000 | +215.7% | 61,826 | +227.1% | 0.00% | +300.0% |
| Q1 2014 | $89,000 | +39.1% | 18,902 | +48.7% | 0.00% | 0.0% |
| Q4 2013 | $64,000 | -54.9% | 12,715 | -44.4% | 0.00% | -50.0% |
| Q3 2013 | $142,000 | – | 22,873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |